Wall Street analysts have been busy making adjustments to their outlooks on a number of high-profile companies. This week saw a flurry of price target changes and rating updates, offering valuable insights into the evolving sentiment surrounding these stocks.
Travere Therapeutics, Inc. (TVTX)
HC Wainwright & Co. lowered its price target for Travere Therapeutics from $23 to $18, although analyst Ed Arce maintained a Buy rating. Despite the lowered target, Travere Therapeutics shares gained 3.4% to close at $15.04 on Thursday.
Rocket Lab USA, Inc. (RKLB)
Keybanc increased its price target for Rocket Lab from $8 to $11, with analyst Michael Leshock upholding an Overweight rating. The positive outlook was reflected in Rocket Lab’s share performance, which rose 0.8% to close at $8.69 on Thursday.
MP Materials Corp. (MP)
Baird raised its price target for MP Materials from $20 to $25, with analyst Ben Kallo maintaining an Outperform rating. This optimistic view translated to a 4.6% gain for MP Materials shares, closing at $16.90 on Thursday.
ESCO Technologies Inc. (ESE)
Stephens & Co. boosted its price target for ESCO Technologies from $135 to $145, while analyst Tommy Moll kept an Overweight rating. The positive outlook contributed to ESCO Technologies shares rising 1.4% to close at $126.37 on Thursday.
Accenture plc (ACN)
Baird increased its price target for Accenture from $350 to $370, but analyst David Koning maintained a Neutral rating. Despite the neutral rating, Accenture shares gained a strong 5.6% to close at $355.81 on Thursday.
Jabil Inc. (JBL)
B of A Securities raised its price target for Jabil from $135 to $150, with analyst Ruplu Bhattacharya maintaining a Buy rating. This optimistic sentiment translated into a significant 11.7% gain for Jabil shares, closing at $126.65 on Thursday.
Agios Pharmaceuticals, Inc. (AGIO)
Leerink Partners lowered its price target for Agios Pharmaceuticals from $60 to $56 and downgraded the stock from Outperform to Market Perform, resulting in a 2% decline for Agios Pharmaceuticals shares, closing at $48.05 on Thursday.
Wynn Resorts, Limited (WYNN)
Morgan Stanley raised its price target for Wynn Resorts from $97 to $104 and upgraded the stock from Equal-Weight to Overweight. The optimistic outlook contributed to an 8.2% gain for Wynn Resorts shares, closing at $91.03 on Thursday.
Micron Technology, Inc. (MU)
Baird lowered its price target for Micron Technology from $172 to $150, although analyst Tristan Gerra maintained an Outperform rating. Despite the lowered target, Micron shares gained a strong 14.7% to close at $109.88 on Thursday.
Udemy, Inc. (UDMY)
Morgan Stanley slashed its price target for Udemy from $10 to $7.5 and downgraded the stock from Equal-Weight to Underweight. Despite the negative outlook, Udemy shares gained 1.3% to close at $8.13 on Thursday.
These analyst rating changes provide valuable insights into the current market sentiment and future potential of these companies. It’s important to note that analyst opinions can vary, and investors should always conduct their own research before making any investment decisions.
